Bird & Bird LLP | Australia, China, France, etc. | 15 Mar 2024
In disputes concerning the alleged infringement of intellectual property ("IP") rights, a court may grant a preliminary injunction ("PI"), for the…
Ropes & Gray LLP | Asia-Pacific, China, India, etc. | 8 Mar 2024
The recent BioCentury East-West Summit in Singapore shed light on the increasing prominence of Asia in the global life sciences industry, with Asia…
Sidley Austin LLP | Singapore | 6 Mar 2024
=As Singapore’s founding father and first Prime Minister recognized, a small nation-state with limited Natural Resources can succeed in the modern…
Baker McKenzie | Singapore | 5 Mar 2024
The Singapore Association of Pharmaceutical Industries (SAPI) has released a set of Guidelines for Interactions with Patients, Caregivers and…
Baker McKenzie | Singapore | 29 Feb 2024
The Ministry of Health (MOH) reported that it is investigating a clinic providing a telemedicine service for allegedly issuing medical certificates…
Baker McKenzie | Singapore | 29 Feb 2024
On 30 January 2024, the Health Science Authority (HSA) announced it had seized over 1.12 million units of illegal health products and removed…
Baker McKenzie | Singapore | 29 Feb 2024
Psychologists have called for greater regulation and recognition of their profession, especially with the national push for better mental…
In-Depth
PRO
Editor:
Peter Bogaert
Covington & Burling LLP
In-Depth: Life Sciences Law (formerly The Life Sciences Law Review) is an overview of the legal and regulatory frameworks governing pharmaceutical, biotechnology and medical device companies in key jurisdictions worldwide. It covers the major rules and restrictions throughout the life cycle of regulated products, from discovery to clinical trials, the marketing authorisation process and post-approval controls. It also examines the most consequential recent trends and developments in the sector.